FDA approves Livsayis for generalized myasthenia gravis

The FDA has approved Livsayis as the first small interfering RNA treatment for generalized myasthenia gravis with subcutaneous dosing to be administered every 3 months.
Livsayis (cemdisiran, Regeneron Pharmaceuticals) was accepted for priority review by the FDA in July. The treatment has shown rapid and sustained disease control, Tuan Vu, MD, professor of neurology at the University of South Florida Morsani College of Medicine, said in a press release.
“Livsayis delivered rapid, deep disease control, maintained through the end of dosing intervals, and offers a four-times-a-year subcutaneous

Q&A: Doctors ‘cannot stay on the sidelines’ of AI

ORLANDO — Familiarity with AI is increasingly necessary in the clinic, and doctors need to be able to discuss their use of AI with patients in an informed way, according to speakers at AIMed26.
“AI is ... already part of healthcare, whether we’re fully prepared for it or not,” Orvil F. Martínez, MD, CEO of Advance Medical Research Center and director of the AI Coalition of Puerto Rico, told Healio, adding, “AI literacy is quickly becoming part of clinical competency.”
It is a trend “that certainly is not going away,” Rafael J. Grossmann, MD, MSHS, FACS, general, trauma and acute care surgeon at

Sogroya approved for kids with Turner syndrome growth failure

The FDA has approved a once-weekly injection for children aged 2.5 years and older with growth failure associated with Turner syndrome, Novo Nordisk announced in a press release.
The approval makes somapacitan-beco (Sogroya) the first and only once-weekly, long-acting growth hormone for children with Turner syndrome, a chromosomal condition that leads to short stature in girls, according to the release. The injection comes in 5 mg, 10 mg and 15 mg doses.
“Daily growth hormone therapy works well, but staying consistent with treatment over time can be difficult — especially in conditions like

Woman presents with facial papules after exosome injections

SAN DIEGO — A middle-aged woman walked into a dermatology clinic with facial granulomas that appeared weeks after receiving injectable exosomes at an unlicensed medical facility, according to a speaker.
Exosome products have surged in popularity in the United States. Used widely in Korea, exosomes are extracellular vesicles that are trending for their perceived skin care benefits, as Healio previously reported. While many dermatologists have acknowledged that evidence suggests topical exosomes have potential to heal the skin, there are currently no FDA-approved exosome products, and the agency

Five finger relaxation: A mindful approach to stress

Five finger relaxation is a structured technique that can help individuals reduce stress, manage pain and practice mindfulness.
It can be performed almost anywhere and adapted to include gratitude reflections.
Five finger relaxation combines diaphragmatic breathing with tactile and visual cues. It can be practiced by adults and children and incorporated into daily routines. For example, it may serve as a microbreak during the workday to help manage stress.
{{VIDEO}}
Gratitude meditation can be incorporated into five finger relaxation as an additional mindfulness practice.
Gratitude meditation is a

Healthcare companies need clear guidelines for AI

ORLANDO — Healthcare companies that use AI tools need to have a full understanding of what information the tools can access and enforceable limits on what they can do, according to a speaker at AIMed26.
Governing how AI tools are used and ensuring their security should become part of daily operations for healthcare companies, Dennis Chornenky, founder and CEO of Domelabs, told attendees. In his presentation, Chornenky discussed how companies can practically implement guardrails to minimize AI exposure in their operations.
“Clinicians share that responsibility by helping define appropriate use,

Lorundrostat shows long-term efficacy in uncontrolled hypertension

CHICAGO — Lorundrostat delivered sustained BP control and consistent safety for up to 48 weeks in adults with uncontrolled or resistant hypertension, with no clinically relevant safety findings, a speaker reported.
Transform-HTN was the largest study to date of lorundrostat (Mineralys Therapeutics), an aldosterone synthase inhibitor, for treatment of uncontrolled hypertension despite background therapy, Manish Saxena, MBBS, deputy clinical director and researcher at Barts Health and Queen Mary University in London, said during a presentation at the American Heart Association Scientific

Liposomal bupivacaine may reduce opioid use after TKA

Intraoperative liposomal bupivacaine may be associated with decreased opioid use and better recovery outcomes in patients after total knee arthroplasty, according to results.
“Using modern [enhanced recovery after surgery] protocols — devices, therapeutics like liposomal bupivacaine — can really move the needle in terms of opioid use and pain control after surgery,” Vinod Dasa, MD, FAAOS, cochair of American Academy of Orthopaedic Surgeons’ National Initiative to Reduce Opioid Use in Orthopaedics, told Healio. “Ideally, we get to an opioid-free surgery, and the more tools we can use to get

Early weight loss with tirzepatide tied to long-term maintenance

NATIONAL HARBOR, Md. — Adults with obesity using once-weekly tirzepatide were more likely to maintain weight loss if they had greater weight reduction early in therapy, according to a presenter.
As Healio previously reported, the SURMOUNT-MAINTAIN phase 3 trial found that 67.9% of adults receiving 10 mg or 15 mg tirzepatide (Zepbound, Eli Lilly) for 60 weeks were able to maintain more body weight when they continued therapy at the maximum tolerated dose or titrated down to 5 mg for 1 year instead of discontinuing therapy entirely. In a post hoc analysis of SURMOUNT-MAINTAIN presented at

Q&A: Distinct cancer incidence, survival based on month of year

Thousands of cancer diagnoses may be delayed during the holiday season.
October may raise awareness for more than just breast cancer.
And melanoma diagnoses appear to coincide with the sunny weather.
An evaluation of the 10 most common malignancies in the U.S. from 2001 to 2019 — more than 30 million cancer cases — showed distinct month-to-month variation in total, local and distant-stage diagnoses, as well as OS.
Notable trends included:
“This is an opportunity, a call to action for our hospital, healthcare system, and cancer care teams to look at this critically, especially at your own